Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of this study is to see if Isatuximab can alter the immune system in patients with multiple myeloma or lymphoma upon recovery from the autologous stem cell transplantation. The investigators will see if Isatuximab makes changes to the immune system so that upon recovery from the transplant, the immune system can fight the cancer. This study will have two arms. On one arm (control arm), participants will receive standard transplant procedures and on the other arm (experimental arm), p
Sponsor: Divaya Bhutani
Check if you qualify for this multiple myeloma clinical trial in Detroit, MI
If you're searching for multiple myeloma treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.